Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00262977 · ClinicalTrials.gov registry record · NA

Improving Aspirin Use in Diabetes: A Cluster Randomized Trial

A NA study of Diabetes Mellitus, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT00262977 is a NA study of Diabetes Mellitus that has completed, run by Northwestern University. The registered enrollment target is 300 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00262977, a NA study of Diabetes Mellitus, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

Our aim is to determine if a patient-directed intervention is more effective than computerized clinician reminders alone for improving aspirin use in adults with diabetes.

Conditions Studied

Interventions

  • BEHAVIORAL Electronic prompt plus patient-directed intervention
  • BEHAVIORAL Electronic prompt to clinician to prescribe aspirin

Study Locations (1)

Illinois

  • Northwestern University, Division of General Internal Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2004-09
Est. Completion 2005-05
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT00262977

The ClinicalTrials.gov registry entry for NCT00262977 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (84% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Electronic prompt plus patient-directed intervention is the first listed.

NCT00262977 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00262977 about?

NCT00262977 is a clinical study titled "Improving Aspirin Use in Diabetes: A Cluster Randomized Trial". Our aim is to determine if a patient-directed intervention is more effective than computerized clinician reminders alone for improving aspirin use in adults with diabetes.

What is the current status of trial NCT00262977?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2004-09. Estimated completion is 2005-05.

What conditions does trial NCT00262977 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT00262977?

The interventions under investigation include: Electronic prompt plus patient-directed intervention (BEHAVIORAL), Electronic prompt to clinician to prescribe aspirin (BEHAVIORAL).

Who is sponsoring clinical trial NCT00262977?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00262977 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.